4.8 Article

The human brain NGF metabolic pathway is impaired in the pre-clinical and clinical continuum of Alzheimers disease

Journal

MOLECULAR PSYCHIATRY
Volume 26, Issue 10, Pages 6023-6037

Publisher

SPRINGERNATURE
DOI: 10.1038/s41380-020-0797-2

Keywords

-

Funding

  1. Canadian Institutes of Health Research (CIHR)
  2. Alzheimer Society of Canada
  3. Merck Canada
  4. NIA [P30AG10161, R01AG15819]
  5. McGill Integrated Program in Neuroscience
  6. Bourse Postdoctorale from the Fonds de Recherche du Quebec Sante (FRQS)
  7. CIHR Doctoral Award

Ask authors/readers for more resources

The study revealed that in Alzheimer's disease, there are changes in the metabolism of NGF, leading to disease progression. Mature NGF degradation is enhanced while proNGF maturation is impaired, with these changes correlating with cognition, pathology, and cholinergic tone.
The NGF metabolic pathway entails the proteins that mature pro-nerve growth factor (proNGF) to NGF and those that degrade NGF. Basal forebrain cholinergic neurons require NGF for maintenance of cholinergic phenotype, are critical for cognition, and degenerate early in Alzheimer's disease (AD). In AD, NGF metabolism is altered, but it is not known whether this is an early phenomenon, nor how it relates to AD pathology and symptomology. We acquired dorsolateral/medial prefrontal cortex samples from individuals with Alzheimer's dementia, Mild Cognitive Impairment (MCI), or no cognitive impairment with high (HA-NCI) and low (LA-NCI) brain A beta from the Religious Orders Study. Cortical proNGF protein, but not mRNA, was higher in AD, MCI, and HA-NCI, while mature NGF was lower. Plasminogen protein was higher in MCI and AD brain tissue, with plasminogen mRNA not likewise elevated, suggesting diminished activation of the proNGF convertase, plasmin. The plasminogen activator tPA was lower in HA-NCI while neuroserpin, the CNS tPA inhibitor, was higher in AD and MCI cortical samples. Matrix metalloproteinase 9 (MMP9), which degrades NGF, was overactive in MCI and AD. Transcription of the MMP9 inhibitor TIMP1 was lower in HA-NCI. ProNGF levels correlated with plasminogen, neuroserpin, and VAChT while NGF correlated with MMP9 activity. In NCI, proNGF correlated with cerebral A beta and tau deposition and to cognitive performance. In summary, proNGF maturation is impaired in preclinical and clinical AD while mature NGF degradation is enhanced. These differences correlate with cognition, pathology, and cholinergic tone, and may suggest novel biomarkers and therapeutic targets.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available